Grünenthal GmbH

Grünenthal GmbH is a leading Contract Development and Manufacturing Organisation (CDMO) that serves the pharmaceutical industry as a reliable and sustainable strategic partner. With an integrated service model from Active Pharmaceutical Ingredient (API) production to various packaged forms, the company operates as a truly global supplier, serving approximately 100 countries worldwide. Grünenthal GmbH has established robust track and trace capabilities for multiple countries, and possesses extensive expertise in biopharma assembly, labelling, packaging, and nasal Unit Dose Systems (UDS). The company is particularly noted for its proficiency in handling and producing scheduled drugs, with production and warehousing facilities located in Latin America. Additionally, Grünenthal GmbH boasts approvals from prominent regulatory bodies such as the FDA, EMA, ANVISA, and PMDA.

Services include:
- Contract Development and Manufacturing (CDMO)
- Packaging Equipment
- Biopharma assembly
- Labelling
- Packaging
- Nasal UDS
- Scheduled drug production and handling
- Track and trace services

Grünenthal GmbH continues to position itself as a trusted partner in the pharmaceutical sector, dedicated to delivering high-quality services that meet the evolving needs of its clients. For further information, visit grunenthal-pro.com.